|1.||Lundberg, Björn: 2 articles (08/2012 - 11/2009)|
|2.||Behndig, Anders: 2 articles (08/2012 - 11/2009)|
|3.||Cho, S: 2 articles (01/2004 - 05/2001)|
|4.||Park, E M: 2 articles (01/2004 - 05/2001)|
|5.||Volpe, B T: 2 articles (01/2004 - 05/2001)|
|6.||Joh, T H: 2 articles (01/2004 - 05/2001)|
|7.||Brusini, Paolo: 1 article (01/2013)|
|8.||Taloni, Maurizio: 1 article (01/2013)|
|9.||Stecchi, Gaetano: 1 article (01/2013)|
|10.||Sampaolesi, Roberto: 1 article (01/2013)|
|1.||Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
04/01/1993 - "Depending on the degree of myocardial failure, the effectiveness of epinine was reduced, whereas the potency was similar. "
08/22/1986 - "Epinine is a cardiovascular agent used in congestive heart failure because of its dopaminergic and adrenoreceptor agonist properties. "
02/01/1986 - "the 3,4-diisobutyryl ester of N-methyldopamine and to its development as a useful drug for the chronic treatment of congestive heart failure. "
02/01/1986 - "The purpose of this multicenter study was to evaluate the therapeutic efficacy of ibopamine (SB-7505), the 3,4-diisobutyrylester of N-methyldopamine, chronically administered to patients with severe congestive heart failure (CHF) in whom traditional therapy had been ineffective. "
02/01/1992 - "In conclusion, epinine, at concentrations similar to those achieved during therapeutic use of ibopamine, had negligible effect on myocardial contractility and relaxation rate in heart failure patients. "
|3.||Myocardial Ischemia (Ischemic Heart Diseases)
01/01/2013 - "The purpose of the study was to assess the effect of ibopamine (3,4 di-isobutyrrylester of N-methyldopamine), a D1-dopamine agonist, on intraocular pressure (IOP) in offspring of parents with primary openangle glaucoma as a consequence of outflow structures impairment. "
03/01/2004 - "Two Ibopamine (3,4 di-isobutyrylester of N-methyldopamine) 2% eyedrops were instilled 5 minutes apart in one eye selected at random in both glaucoma and normal subjects. "
11/01/1997 - "Our data show that, in isolated working rat heart, the dopaminergic stimulation with low-doses epinine may exert a cardioprotective effect against ischemia-reperfusion damage by modulating endothelial permeability changes and improving coronary microcirculation. "
07/10/2006 - "Previously, we reported that N-acetyl-O-methyldopamine (NAMDA) protects neurons from ischemia via enhancing ERK dependent CREB phosphorylation. "
01/01/2004 - "Previously, we reported that N-acetyl-O-methyldopamine (NAMDA) significantly protected CA1 neurons after transient forebrain ischemia [J Neurosci 19 (1999b) 87.8]. "
01/01/2004 - "A neuroprotective role of extracellular signal-regulated kinase in N-acetyl-O-methyldopamine-treated hippocampal neurons after exposure to in vitro and in vivo ischemia."
11/01/1997 - "The effect of cardiac dopaminergic receptors stimulation with epinine (N-methyldopamine) on reperfusion injury was investigated in isolated working rat heart submitted to 15 min of global ischemia. "
|8.||Levodopa (L Dopa)
|10.||Hexamethonium (Hexamethonium Bromide)